Abstract The interest in plasmid DNA (pDNA) as a biopharmaceutical has been increasing over the last several years, especially after the approval of the first DNA vaccines. New pDNA production strains have been created by rationally mutating genes selected on the basis of Escherichia coli central metabolism and plasmid properties. Nevertheless, the highly mutagenized genetic background of the strains used makes it difficult to ascertain the exact impact of those mutations. To explore the effect of strain genetic background, we investigated single and double knockouts of two genes, pykF and pykA, which were known to enhance pDNA synthesis in two different E. coli strains: MG1655 (wild-type genetic background) and DH5α (highly mutagenized genetic background). The knockouts were only effective in the wild-type strain MG1655, demonstrating the relevance of strain genetic background and the importance of designing new strains specifically for pDNA production. Based on the obtained results, we created a new pDNA production strain starting from MG1655 by knocking out the pgi gene in order to redirect carbon flux to the pentose phosphate pathway, enhance nucleotide synthesis, and, consequently, increase pDNA production. GALG20 (MG1655ΔendAΔrecAΔpgi) produced 25-fold more pDNA (19.1 mg/g dry cell weight, DCW) than its parental strain, MG1655ΔendAΔrecA (0.8 mg/g DCW), in glucose. For the first time, pgi was identified as an important target for constructing a highyielding pDNA production strain.
Introduction
Non-viral gene therapy is a promising approach for the treatment of genetic disorders and acquired diseases and for the prevention of infectious diseases. The discovery that naked plasmid DNA (pDNA) could mediate gene transfer and expression in vivo (Wolff et al. 1990 ) initiated the emergence of a new class of medicinal agents (Prazeres 2011) . Efforts to develop such plasmid biopharmaceuticals have increased over the last several years, especially after the approval of the first veterinary DNA vaccines (Han et al. 2009; Williams et al. 2009a, b) . The relevance of non-viral gene therapy is underscored by the fact that plasmid DNA accounts for 25 % of the vectors used in clinical trials (http://www.wiley.com//legacy/wileychi/genmed/clinical/).
One of the aims of research on plasmid biopharmaceuticals has been the development of Escherichia coli host strains capable of producing the large amounts of pDNA required for clinical trials and, eventually, commercialization (Bower and Prather 2009; Goncalves et al. 2012; Lara and Ramirez 2012) . Roughly speaking, volumetric pDNA titers lower than 250 mg/L are typically obtained in laboratory-scale fermentations (Prazeres 2011) , whereas titers of the order of 1,000-2,100 mg/L have been reported in high-yield, preindustrial fermentations (Carnes et al. 2006; Listner et al. 2006; Phue et al. 2008; Luke et al. 2009; Williams et al. 2009a, b) . On a dry cell weight (DCW) basis, the plasmid content of E. coli cells may be expected to vary anywhere between 0.5 and 5.0 % (w/w), depending on the plasmid type, strain, growth conditions, and growth phase (Prazeres 2011 ). E. coli host strains of the K-12 and B type with diverse mutagenized genetic backgrounds, such as DH5, DH5α, DH10B, JM108, JM101, and BL21, have all been used for pDNA production (Bower and Prather 2009; Carnes and Williams 2007; Cunningham et al. 2009a, b; Prather et al. 2003; Williams et al. 2009a, b) . However, most of these strains were originally developed to facilitate the cloning of heterologous genes and for the production of recombinant proteins and, thus, may not be the most appropriate for pDNA manufacturing. A more rational approach has been pursued recently, whereby genes are selected and mutated on the basis of E. coli central carbon metabolism and plasmid properties. This has led to the generation of a plethora of new pDNA production strains, such as DH5αΔfruR (Ow et al. 2007 ), BL21ΔendA-ΔrecA (Phue et al. 2008 ), JM101ΔpykFΔpykA (Cunningham et al. 2009a, b) , DH5αzwf:rpiA + (Williams et al. 2009a, b) , and W3110ΔPTSGalP + ΔpykA (Pablos et al. 2011) . Reducing acetate and enhancing nucleotide production are some of the strategies that are used to increase pDNA yields. Knockouts of selected genes, such as pykF, pykA, ackA-pta, and poxB, have been explored to reduce acetic acid formation in pDNA production strains (Carnes et al. 2011; Cunningham et al. 2009a, b; Pablos et al. 2011) . Genes in the pentose phosphate pathway, such as zwf and rpiA, have also been overexpressed in order to enhance nucleotide production for pDNA synthesis (Wang et al. 2006; Williams et al. 2009a, b) . However, most of these mutations were made in strains with highly mutagenized genetic backgrounds. Thus, it is unclear whether the specific strain background had an effect on the mutations introduced. In addition, these highly mutated strains exhibit a lower growth rate than parental (wild-type) strains, a characteristic that suggests a less healthy organism.
The trade-off between strain engineering and fermentation strategy is still a hurdle for the development of new pDNA production strains. Differences in fermentation strategies (batch or fed-batch; O' Kennedy et al. 2003; Ow et al. 2007 Ow et al. , 2009 , medium composition, and carbon source (glucose or glycerol; Oh and Liao 2000) were previously shown to affect E. coli metabolism and should also be taken into consideration when producing pDNA. It is well known that glycerol has the advantage of minimizing acetate formation in fermentation processes, and it is becoming an inexpensive and attractive carbon source (Carnes et al. 2006; Carvalho et al. 2012; Lara et al. 2011) . On the other hand, glucose has been used for several years in high-density cultures and for pDNA production and is both accessible and inexpensive (Luli and Strohl 1990) . High acetate formation has been observed with glucose; however, the accumulation profiles depend on the strain (Phue et al. 2005 ). E. coli strains have been engineered to optimize glucose uptake and reduce acetate formation (De Anda et al. 2006) . For example, the strain VH33 (PTS -GalP + ), a derivative of W3110 with an inactive phosphotransferase system (PTS) and a strong promoter for galP, has shown improved production of pDNA (Pablos et al. 2011; Soto et al. 2011) . Interestingly, high-yield pDNA production was shown with strain BL21ΔendAΔrecA in both glucose and glycerol, while DH5α produced high pDNA yields only in glycerol (Phue et al. 2008) .
In this work, we set out to enhance pDNA production by rationally mutating key genes of the glycolytic pathway. We first chose genes which had already been shown to increase pDNA yields, pykF and pykA (Cunningham et al. 2009a, b; Pablos et al. 2011) , and deleted them in two different strains: MG1655ΔendAΔrecA, a nearly wild-type genetic background, and DH5α, a commonly used but highly mutagenized strain. Deletions of endA and recA were made in MG1655 in order to minimize recombination and nonspecific digestion of DNA (Phue et al. 2008; Summers 1998) . We also analyzed the influence of carbon source (glucose versus glycerol) among the different strains developed. Finally, we explored the effect of a previously untested mutation with the introduction of a new knockout, pgi, in MG1655ΔendAΔrecA to redirect carbon flow into the pentose phosphate pathway (PPP) and promote nucleotide synthesis.
Material and methods

Strains and plasmids
The bacterial strains used in this study are indicated in Table 1 . MG1655 was kindly donated by Professor Gregory Stephanopoulos of the Department of Chemical Engineering at the Massachusetts Institute of Technology (Cambridge, MA, USA). Gene deletions of endA, recA, pykF, pykA, and pgi in MG1655 and JM101 were carried out with P1 transduction using the following strains from the Keio collection (Baba et al. 2006) : kan]. The recA gene was always the last to be deleted since P1 transduction requires an active RecA recombinase. The kanamycin cassette was removed using plasmid pCP20 as described by Datsenko and Wanner (2000) , and successfully constructed mutant strains were verified by colony PCR using appropriate primers. The standard protocol for the inactivation of chromosomal genes (Datsenko and Wanner 2000) was adapted to knock out pykF and pykA in DH5α. Briefly, DH5α was transformed with a recA-containing plasmid, pKD46recA + , and RecA recombinase expression was induced with arabinose. DH5α(pKD46recA + ) was transformed with the specific PCR fragment generated using appropriate primers, and homologous recombinants were selected with kanamycin. The plasmid pKD46recA
+ is temperature-sensitive and was cured by raising the temperature. The remaining steps of the protocol were performed as described previously by Datsenko and Wanner (2000) . All strains were transformed with plasmid pVAX1GFP (3,697 bp), derived from Invitrogen's (Carlsbad, CA) pVAX1LacZ as described previously (Azzoni et al. 2007 ).
Medium and growth conditions
Transformed strains were maintained on agar plates containing 30 μg/mL of kanamycin. A seed bank was prepared from single colonies picked from each plate and inoculated in Luria-Bertani medium supplemented with 30 μg/mL of kanamycin. Cultures were grown to mid-exponential phase at 250 rpm, 37°C, and frozen at −80°C in 15 % (v/v) final concentration glycerol. The inoculum was prepared from frozen seed stocks in complex medium (Bacto peptone, 10 g/L; yeast extract, 10 g/L; (NH 4 ) 2 SO 4 , 3 g/L; K 2 HPO 4 , 3.5 g/L; KH 2 PO 4 , 3.5 g/L; thiamine, 199 mg/L; MgSO 4 , 1.99 g/L; trace element solution, 1 mL/L; Listner et al. 2006) supplemented with 30 μg/mL of kanamycin, grown to mid-exponential phase, and then used to inoculate batch cultures to an initial optical density at 600 nm (OD 600 ) of approximately 0.1. Cultures were grown at 37°C for 24 h in 250-mL shake flasks containing 50 mL of the complex medium supplemented with 30 μg/mL of kanamycin, initial pH of 7.1, and aeration by shaking at 250 rpm. Glucose and glycerol were used as the primary carbon sources, as indicated in "Results." Cells were sampled at 6, 12, and 24 h to quantify glucose, glycerol, and acetate, and at 12 and 24 h to quantify pDNA.
Biomass quantification
Samples were taken every 3 h to determine biomass concentration. OD 600 was measured in a Beckman Coulter DU 800 spectrophotometer. Dry cell weight (DCW) was determined using a vacuum filtration system. Ten milliliters of each sample was filtered in previously weighed filter papers and then dried at 42°C. A linear correlation was determined between cell concentration (in grams per liter) and OD 600 .
Plasmid DNA quantification Plasmid DNA was quantified from crude lysates prepared from OD 600 010 cell pellets using the method described by Listner et al. (2006) . The method was modified slightly: cell pellets were harvested by centrifugation at 5,000×g for 15 min, the 37°C incubation took place with 250 rpm shaking, and 5 μL of RNase A solution (10 mg/mL) was used per milliliter of lysate. The resulting lysates were analyzed using a Gen-Pak FAX anion exchange column (Waters Corporation) on an Agilent 1100 Series HPLC system. The HPLC method was run at a constant flow rate of 0.75 mL/min and consisted of a 10-min linear NaCl gradient from 300 to 660 mM, followed by 5.5 min at 1 M NaCl, after which the column was flushed with 0.04 M phosphoric acid for 4.5 min. Before the next sample injection, the column was equilibrated with 300 mM NaCl for 10 min. Plasmid DNA eluted at approximately 610 mM NaCl and was detected at 260 nm with a diode array detector. A highly linear standard curve of pVAX1GFP was prepared using pDNA purified with the Hi-Speed QIAfilter Plasmid Maxi Kit (Qiagen) and quantified using absorbance at 260 nm on an Implen NanoPhotometer.
Metabolite quantification
To determine the concentration of glucose, glycerol, and acetic acid, culture samples were centrifuged at 5,000×g for 15 min and the aqueous supernatant used for HPLC analysis on an Agilent 1100 Series HPLC system equipped with an Aminex HPX-87H anion exchange column (BioRad Laboratories) and refractive index detector. The LC method was run at a constant flow rate of 0.6 mL/min, with 5 mM H 2 SO 4 as the mobile phase, at 50°C for 25 min.
Statistical analyses
The effect of the gene knockouts was measured by pDNA yield quantification. T tests for independent samples (SSPS Statistics) were done to identify significant differences in pDNA yields between parental and mutated strains. Differences were considered statistically significant when the p value was<0.05. At least three independent duplicate experiments were conducted in order to confirm the results. Standard error of the mean (SEM) was calculated for all measurements of pDNA yields, biomass, acetate, and growth rate.
Results
Effect of carbon source on pykF and pykA knockout strains Cunningham et al. (2009a, b) demonstrated the benefits of the double pykF-pykA mutations in a JM101 strain grown on glucose (Fig. 1) . We chose to investigate these same mutations in the nearly wild-type MG1655ΔendAΔrecA and in the commonly used DH5α strain using either glycerol or glucose as the primary carbon source. The first experiments were conducted with an initial concentration of glycerol and glucose of 20 g/L and with MG1655ΔendAΔrecA, GALG1011 (MG1655ΔendAΔrecAΔpykFΔpykA), DH5α, and DH5αΔpykFΔpykA, all carrying pVAX1GFP. MG1655ΔendAΔrecA and DH5α grew faster than their respective pykF and pykA double knockout mutant strains in both glucose and glycerol. However, a higher biomass content was obtained in glycerol. GALG1011 produced less acetate than MG1655ΔendAΔrecA in both carbon sources. In contrast, DH5α and DH5αΔpykFΔpykA produced similar amounts of acetate. In general, less acetate was obtained in glycerol for all strains ( Table 2) . The double knockout of pykF and pykA had a negative impact on pDNA production in both strains when using glycerol as the carbon source (Table 3) . On the other hand, the double knockout increased the pDNA yield twofold in GALG1011 versus MG1655ΔendAΔrecA when glucose was the main carbon source. In glucose, the PTS is able to couple pyruvate formation with carbohydrate transport, partially mitigating the effect of pyk deletions. However, the PTS system is not utilized for glycerol uptake; hence, this additional source of pyruvate is not available (Oh and Liao 2000) . Nevertheless, pDNA yields were significantly lower in glucose than in glycerol for all Pyk mutant strains when the initial concentration of both carbon sources was 20 g/L (Table 3) . It has been reported that 10 g/L of glucose can inhibit pDNA synthesis in E. coli B (Zhi-nan et al. 2005) and that E. coli K-12 grows slower and accumulates more acetate than B strains at high glucose concentrations (Phue et al. 2005) . Therefore, inhibition of pDNA synthesis could also be expected in K-12 strains with high glucose. Of the strains and conditions examined, MG1655ΔendAΔrecA was the best producer of pDNA in glycerol, although it produced the highest quantity of acetate (Tables 2 and 3 ). It is known that acetate secretion can shuttle carbon away from nucleotide synthesis, which could be disadvantageous for pDNA formation, but the exact effect of acetate on pDNA production is not yet elucidated (Carnes et al. 2011; Wang et al. 2006 ).
Glucose inhibition in plasmid DNA production
To determine the effect of glucose concentration on pDNA production, MG1655ΔendAΔrecA and GALG1011 bearing pVAX1GFP were grown in three different conditions: 5 g/L of glucose initially plus 10 g/L of glucose after 12 h (5+ 10 g/L), 10 g/L of glucose initially plus 10 g/L of glucose after 12 h (10+10 g/L), and 20 g/L with no extra addition of glucose. MG1655ΔendAΔrecA and GALG1011 produced fivefold and fourfold more pDNA, respectively, in 5+10 g/L than 20 g/L of glucose (Table 3) . However, when the initial glucose concentration was 5 g/L, the difference in pDNA specific yield (in milligrams per gram DCW) between these strains was less than twofold (Table 3) . In 5+10 g/L glucose, GALG1011 still produced less acetate and grew more slowly than MG1655ΔendAΔrecA (Table 2) . Similar biomass was formed for both strains, and the final biomass achieved in 5 + 10 g/L glucose was comparable to that obtained in glycerol, though the pDNA yield was still higher in glycerol. Experiments were also performed with glucose addition after 9 h, but no difference was observed in pDNA yields (data not shown).
After determining the best glucose concentration, 5+ 10 g/L, for pDNA production in MG1655ΔendAΔrecA and GALG1011, we tested DH5α and DH5αΔpykFΔpykA in order to determine whether the negative performance of the double mutant with 20 g/L glucose (Table 3 ) was due to inhibition or to strain genetic background. pDNA production increased twofold in DH5α when moving from 20 g/L Fig. 1 Gene knockout strategies to improve plasmid DNA production in E. coli. The knockout of the phosphoglucose isomerase (pgi) gene redirects glycolytic flux, increasing fluxes in the pentose phosphate pathway and enhancing nucleotide synthesis and NADPH production. Glycolysis is down-regulated, but proceeds via the formation of fructose-6-phosphate and glyceraldehyde-3-phosphate. The knockouts of pyruvate kinase genes pykF and pykA reduce acetate formation and increase fluxes in the pentose phosphate pathway. This figure represents a simplified version of E. coli central metabolism. Dark arrows represent high carbon flow in the pentose phosphate pathway, light arrows represent the down-regulation of glycolysis, and blank arrow represents null carbon flow. G6P glucose-6-phosphate, F6P fructose-6-phosphate, FDP fructose-1,6-diphosphate, G3P glyceraldehyde-3-phosphate, PEP phosphoenolpyruvate, 6GPC 6-phosphogluconate, RU5P ribulose-5-phosphate, XU5P xylulose-5-phosphate, R5P ribose-5-phosphate, S7P sedoheptulose-7-phosphate, E4P erythrose-4-phosphate, PTS phosphotransferase system glucose to 5+10 g/L glucose. However, the negative effect of pykF and pykA knockouts was maintained. Therefore, it appears that the genetic background of DH5α is suppressing the positive effects of pykF and pykA gene knockouts observed in GALG1011.
Effect of strain background on pykF and pykA double knockouts
As stated previously, the beneficial effects of the pykF-pykA double knockout for pDNA production were demonstrated in JM101 grown in glucose (Cunningham et al. 2009a, b) . There are no reports about the behavior of JM101ΔpykFΔpykA bearing plasmid in glycerol. To further examine the effect of strain genetic background, we decided to construct JM101ΔpykFΔpykA and to test it in the same rich medium and conditions as GALG1011 and DH5αΔpykFΔpykA. The loss of Pyk is expected to reduce acetate accumulation, and glycerol is frequently used for the same purpose. Thus, the double mutations are not expected to favor pDNA production in glycerol over the unmutated strain; however, because this carbon source was not previously tested, it is unclear whether the effect of the mutations would be negative or neutral. Consistent with the results presented by Cunningham et al. (2009a, b) , JM101ΔpykFΔpykA produced twofold more pVAX1GFP (5.3 or 2.5 mg/g DCW) than JM101 (2.6 or 1.3 mg/g DCW) when grown in 5 or 20 g/L glucose, respectively. However, as with the other engineered strains, JM101ΔpykFΔpykA (2.2 mg/g DCW) produced less pDNA than JM101 in glycerol-rich medium (8.4 mg/g DCW; Table 3 ). In general, the double knockout of pykF and pykA was effective in MG1655ΔendAΔrecA and JM101 in glucose, but it was not beneficial in DH5α. The highly mutagenized genetic background of DH5α appears to affect the pykF and pykA mutation.
Effect of single knockouts of the pykF or pykA gene
The previous results showed that the pykF and pykA double knockout can be beneficial in glucose and that the mutation had a positive effect in MG1655ΔendAΔrecA and JM101 (Table 3) . Nevertheless, the pykF and pykA mutant strain GALG1011 still produced much less plasmid in glucose (6.6 mg/g DCW) than the nearly wild-type strain, MG1655ΔendAΔrecA, in glycerol (11.2 mg/g DCW; Table 3 ).
In an effort to increase pDNA yields, we decided to investigate pykF or pykA single knockouts in MG1655ΔendAΔrecA. A single knockout could be more effective than the double knockout for pDNA production in glucose because more pyruvate would be formed and higher ATP yields would be obtained through glycolysis. At the same time, carbon flux would be boosted to the pentose phosphate pathway, increasing nucleotide synthesis (Siddiquee et al. 2004a, b) . For example, Pablos et al. (2011) showed that a single pykA knockout increased pDNA production threefold in W3110ΔPTSGalP + in glucose. To determine the effect of a pykF or pykA single knockout in MG1655ΔendAΔrecA, we generated strains GALG10 ( M G 1 6 5 5 Δ e n d A Δ r e c A Δ p y k F ) and GALG11 (MG1655ΔendAΔrecAΔpykA) and tested them in glucose and glycerol under the same conditions as described previously (Table 3 ). In both carbon sources, one single mutation was found to be more effective for pDNA production than the double mutation. In glycerol, MG1655ΔendAΔrecA, GALG10, and GALG11 produced similar amounts of pDNA (11.2, 8.6, and 10 .3 mg/g DCW, respectively). In contrast, GALG10 (10.5 mg/g DCW) and GALG11 (13.1 mg/g DCW) produced more pDNA than MG1655ΔendAΔrecA (3.6 mg/g DCW) or GALG1011 (6.6 mg/g DCW) in glucose. GALG11 achieved high pDNA yields in glucose (13.1 mg/g DCW), even in comparison with the yields obtained with MG1655ΔendAΔrecA in glycerol (11.2 mg/g DCW; Table 3 ). Nevertheless, both GALG10 and GALG11 produced little pDNA when the initial concentration of glucose was 20 g/L (≤1 mg/g DCW).
Single mutations in pykF or pykA genes were also constructed in DH5α, generating the strains DH5αΔpykF and DH5αΔpykA. Surprisingly, DH5αΔpykF (5.9 mg/g DCW) produced more pDNA than DH5α (1.8 mg/g DCW) in glucose. On the contrary, DH5αΔpykA (0.9 mg/g DCW) displayed a behaviour similar to DH5αΔpykFΔpykA (0.3 mg/g DCW) and produced much less pDNA. Although the pykF single knockout had positive effects in DH5α, the final pDNA yields obtained with DH5α and DH5αΔpykF bearing pVAX1GFP were lower than the ones obtained with GALG10 and GALG11 (Table 3) .
Effect of pgi knockout on plasmid DNA production The main advantages of removing pyruvate kinase (Pyk) in a pDNA production strain through the deletion of both pykF and pykA genes would be the reduction of acetate and the increase of carbon flux into the PPP. On the other hand, the total lack of Pyk could reduce the energy available for the cells by reducing the ATP content. In this work, we have shown that deletion of both pyruvate kinase isozymes increased pDNA production in the parental strain MG1655ΔendAΔrecA in glucose. However, higher amounts of pDNA were obtained when only pyruvate kinase I or II was absent in the parental strain in glucose, a result that suggests the importance of generating some pyruvate and completing glycolysis.
To increase the pentose phosphate pathway flux without compromising the energy obtained from the generation of pyruvate, we tried a different strategy in order to enhance nucleotide production and reduce glycolytic flux at the same time (Fig. 1) . It has been reported that strains carrying highcopy pDNA require extra synthesis of nucleotides and that the carbon flux into the PPP may not be sufficient to meet cellular needs (Flores et al. 2004 ). The elimination of phosphoglucose isomerase (Pgi) aims to redirect the carbon flux into the PPP, enhance the synthesis of nucleotides, and also provide high amounts of reducing cofactors (i.e., NADPH). Pgi mutant strains were recently reported to improve the production of xylitol (Chin and Cirino 2011; Chin et al. 2009 ), chiral compounds for the pharmaceutical market (Siedler et al. 2011) , and second-generation biofuels (Yao et al. 2011) . GALG20 (MG1655ΔendAΔrecAΔpgi) produced threefold more pVAXGFP pDNA (11.6 mg/g DCW) than MG1655ΔendAΔrecA in 5 + 10 g/L glucose (3.6 mg/g DCW). In glycerol, GALG20 produced similar amounts of pDNA to MG1655ΔendAΔrecA (Fig. 2) . Surprisingly, this strain had the best performance in 20 g/L of glucose, producing 25-fold more pDNA (19.1 mg/g DCW) than the parental strain (0.8 mg/g DCW) and 46 or 65 % more, respectively, than the previously best identified performers, GALG11 in 5+ 10 g/L glucose (13.1 mg/g DCW) and MG1655ΔendAΔrecA in 20 g/L glycerol (11.5 mg/g DCW).
Discussion
The de novo design of E. coli strains specifically for pDNA amplification is expected to enhance the production yields when compared to strains with highly mutagenized genetic backgrounds. In this study, we performed a series of mutations in the wild-type MG1655 strain and in the laboratory strain DH5α in order to improve pDNA yields. The genes coding for pyruvate kinase (pykA, pykF) and phosphoglucose isomerase (pgi) were selected as targets due to their role in the PPP (Fig. 1) .
In order to reduce acetate and increase carbon flux into the PPP, a double knockout of pykF and pykA was first created. Our results show that the strain genetic background can indeed interfere in the outcome of mutations which are otherwise rationally designed. Of the Pyk mutant strains examined, the strains derived from the nearly wild-type MG1655ΔendAΔrecA (GALG10 and GALG11) were the best producers of pDNA, whereas DH5αΔpykFΔpykA and DH5αΔpykA were the worst producers of pDNA in glucose (Table 3 ). The negative effect of the pykF and pykA double knockout on the production of pDNA in DH5α could be ascribed to the interaction between the strain genotype and the new mutations added to the strain, though it is not clear which specific mutations result in the negative phenotype. In contrast, DH5αΔpykF produced more plasmid than DH5α in glucose, a result that points to an essential role of the pykA gene in DH5α. Although, DH5αΔpykF had increased pDNA yields when compared to DH5α, the obtained yields were lower than those obtained with GALG10 and GALG11. Other advantages associated with the use of the nearly wild-type strain MG1655ΔendAΔrecA as a starting point for strain engineering instead of DH5α include a more robust growth and a lack of auxotrophies that can benefit pDNA production.
Strains with single mutations of either pykF or pykA were found to be more efficient in producing pDNA than strains containing the double mutation. The synthesis of pDNA was likely more advantageous when the pyruvate kinase activity was reduced, as opposed to abolished, because glycolytic flux was down-regulated while still enabling additional ATP production and up-regulation of glucose flux through the PPP. For example, Siddiquee et al. (2004a, b) demonstrated that a pykF single knockout in E. coli increased glucose flux through the PPP. Moreover, linear programming has predicted different carbon fluxes for E. coli lacking pyruvate kinase, resulting in different ATP yields (Phalakornkule et al. 2001 ). Since cells, as living organisms, are difficult to phenotypically predict, different strains (MG1655 and DH5α) with the same gene knockout (pykA or pykF) can have diverse carbon fluxes and result in different ATP yields, favoring pDNA synthesis or not.
The abolishment of the pgi gene should redirect glucose-6-phosphate preferentially to the PPP, but glycolysis would continue due to the generation of fructose-6-phosphate and glyceraldeyde-3-phosphate (Fig. 1) . In general, high amounts of NADPH, nucleotides, and ATP would be obtained. Indeed, the inactivation of the pgi gene in E. coli previously resulted in the redirection of glucose predominantly via the PPP, but a minor fraction of glucose was still catabolized in the EntnerDoudoroff pathway (Canonaco et al. 2001) . A large excess of NADPH was detected in Pgi mutant strains (Canonaco et al. 2001; Chin and Cirino 2011; Siedler et al. 2011) , which was shown to improve biotransformations in various processes. However, an excess of NADPH can cause a redox imbalance Fig. 2 Effect of pgi knockout on pDNA specific yield (in milligrams per gram DCW) using MG1655ΔendAΔrecA grown in glycerol and glucose. Strains were grown for 24 h in shake flasks (37°C, 250 rpm) with rich medium supplemented with 5+10 g/L of glucose (white bars), 5+10 g/L glycerol (gray bars), and 20 g/L of glucose (solid bars). Differences between MG1655ΔendAΔrecA and GALG20 were statistically significant (p<0.05) in different concentrations of glucose, but were not statistically significant (p>0.05) in glycerol. The SEM was calculated and represented with error bars in the cell, imposing stress that may appear as a large reduction in growth rate (Charusanti et al. 2010) . In the specific case of pDNA synthesis, a mathematical model has demonstrated that a high generation of NADPH would be effective for increasing yields (Cunningham et al. 2009a, b) . Nevertheless, no Pgi mutant strain has been previously reported for the purpose of producing pDNA. Together, the benefits of increasing glucose flux into the PPP, such as the enhancement of nucleotides and of NADPH generation, turn a Pgi mutant strain into a high-potential pDNA production strain. In fact, GALG20 produced 25-fold more pDNA than its parental strain in 20 g/L of glucose. A previous study has shown that catabolite repression can be relaxed by pgi mutants (Yao et al. 2011) . Indeed, large amounts of biomass (8.8 g/L) and pDNA (19.1 mg/g DCW) and low amounts of acetic acid (0.02 g/L) were formed by GALG20 in high concentrations of glucose. Another advantage of GALG20 for pDNA production was that the growth rate was similar to the parental strain in glucose (Table 2) , whereas a previous study demonstrated a significant reduction of growth rate in a pgi mutant strain grown in the same carbon source (Ahn et al. 2011 ). The differences in the behavior of these two pgi mutants in glucose could be associated with the strain genetic background between the two studies, E. coli MG1655ΔendAΔrecA and KPM SA1 (ΔaraLΔaraK), respectively. In the current work, we have demonstrated that strain background can substantially influence the effect of gene knockouts, such as the differences between the pykF and pykA mutations in MG1655ΔendAΔrecA versus DH5α.
In the pgi mutant strain, the level of glucose-6-phosphate is significantly higher, which can destabilize the PTS system and, in turn, alter the level of cyclic AMP (cAMP) (Morita et al. 2003) . On the other hand, pgi mutant cells up-regulate the catabolite repressor activator (Cra) due to the decrease in fructose-6-phosphate (Yao et al. 2011) . Nevertheless, it is not clear yet how cAMP or Cra mechanisms of gene regulation would correlate with pDNA synthesis. Previous studies suggested that increasing cAMP levels could be associated with the enhancement of pDNA yields (Cunningham et al. 2009a, b) , and the elimination of Cra was shown to increase pDNA (Ow et al. 2009 ). Further work would be necessary to elucidate the role played by cAMP and Cra in plasmid DNA synthesis, and pgi mutant cells could be a useful target to study metabolic network behavior associated with pDNA production. The regulation of glucose-6-phosphate-1-dehydrogenase (Zwf) or other enzymes in the PPP could limit pDNA synthesis. Based on previous evidence (Wang et al. 2006) , ribose phosphate isomerase (Rpi) could also limit nucleotide production because the relative amounts of ribose-5-phosphate (R5P) and xylose-5-phosphate (Xu5P) depend on cellular needs. The overexpression of Zwf and Rpi would be potential alternatives to increase pDNA yields in pgi mutant cells.
Among the strains generated and analyzed, we selected the top 3 pDNA producer strains and compared their performance with the commonly used lab strain, DH5α (Table 4) . GALG20 and GALG11 performed better in glucose while MG1655ΔendAΔrecA and DH5α performed better in glycerol. The pgi mutation in the MG1655ΔendAΔrecA wildtype strain resulted in the best volumetric (140.8 mg/L) and specific (19.1 mg/g DCW) pDNA yields. To our knowledge, this is the highest reported value for specific plasmid yield for a constant temperature batch process. This figure is only comparable to the 19.2 mg/g DCW obtained by Ow et al. (2009) in a fed-batch system with a DH5αΔFruR strain at 37°C. Further experiments will be carried out and different fermentation strategies will be explored in order to investigate the true potential of these high pDNA producer strains.
